318 related articles for article (PubMed ID: 23545906)
1. Evaluation of the efficacy, tolerability, and safety of an over-the-counter acne regimen containing benzoyl peroxide and salicylic acid in subjects with acne.
Kircik LH; Gwazdauskas J; Butners V; Eastern J; Green LJ
J Drugs Dermatol; 2013 Mar; 12(3):259-64. PubMed ID: 23545906
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled double-blinded split-face prospective clinical trial to assess the efficacy, safety, and tolerability of a novel 3-step routine compared to benzoyl peroxide for the treatment of mild to moderate acne vulgaris.
Gern A; Walter J; Xu S; Vakharia PP
Arch Dermatol Res; 2024 May; 316(6):230. PubMed ID: 38787441
[TBL] [Abstract][Full Text] [Related]
3. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
Draelos ZD; Shalita AR; Thiboutot D; Oresajo C; Yatskayer M; Raab S
Cutis; 2012 Jun; 89(6):287-93. PubMed ID: 22838094
[TBL] [Abstract][Full Text] [Related]
5. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
Callender VD
J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
Akarsu S; Fetil E; Yücel F; Gül E; Güneş AT
J Dermatol; 2012 May; 39(5):433-8. PubMed ID: 22035285
[TBL] [Abstract][Full Text] [Related]
8. Randomized, controlled, evaluator-blinded studies conducted to compare the efficacy and tolerability of 3 over-the-counter acne regimens in subjects with mild or moderate acne.
Green L; Kircik LH; Gwazdauskas J
J Drugs Dermatol; 2013 Feb; 12(2):180-5. PubMed ID: 23377391
[TBL] [Abstract][Full Text] [Related]
9. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
[TBL] [Abstract][Full Text] [Related]
10. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
[TBL] [Abstract][Full Text] [Related]
11. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
Cook-Bolden FE
J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
[TBL] [Abstract][Full Text] [Related]
12. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
13. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
Gold LS
Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
[TBL] [Abstract][Full Text] [Related]
16. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
[TBL] [Abstract][Full Text] [Related]
17. Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel.
Eichenfield LF; Krakowski AC
J Drugs Dermatol; 2012 Jul; 11(7):818-24. PubMed ID: 22777222
[TBL] [Abstract][Full Text] [Related]
18. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
[TBL] [Abstract][Full Text] [Related]
19. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
